Rating History for MapLight Therapeutics (MPLT) by UBS

More Stocks Rated by UBS | Latest Ratings for MPLT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/26/2026 Ashwani Verma New Coverage Buy
(N/A)		 48.00
(N/A)		 28.75
(28.82)		 0.24% Details